Federal court cuts Holmes sentence after finding no investor suffered hardship

Elizabeth Holmes just got a year shaved off her prison sentence – because the court found no evidence her investors suffered financial hardship. 

On March 26, 2026, a federal judge in San Jose cut the Theranos founder's sentence from 135 months to 123 months. The reason comes down to a sentencing guideline change that benefits first-time offenders with clean records – and a finding that none of Holmes's investor-victims actually experienced financial hardship from losing their money. 

Here is how it played out. Holmes was convicted in January 2022 on three counts of wire fraud and one count of conspiracy. She had spent years running Theranos, the company at the center of one of the largest fraud cases in Silicon Valley history. Her co-defendant, Ramesh "Sunny" Balwani, was convicted separately. 

At sentencing in November 2022, the court set her offense level at 33 and her Guidelines range at 135 to 168 months. Judge Edward J. Davila gave her 135 months – the lowest the Guidelines allowed – plus three years of supervised release. She reported to prison on May 30, 2023. The court later ordered Holmes and Balwani to pay $452,047,268 in restitution to 12 investor-victims. 

The Ninth Circuit upheld everything in February 2025. Holmes then filed a motion asking the court to reduce her sentence under a 2023 amendment to the federal sentencing guidelines that gives a two-level reduction to defendants who meet a set of criteria, including having zero criminal history points. 

The government fought the motion on one point: it argued Holmes caused substantial financial hardship to her victims, which would disqualify her. The court disagreed. Judge Davila found that every investor in the relevant funding rounds had signed paperwork affirming they could bear the economic risk of their investment and suffer a complete loss without financial impairment. The Probation Office reviewed the victim statements and found no evidence of substantial financial hardship. One investor told the government he lost nearly 15 percent of his personal net worth, but the court said it was unclear how that figure was calculated or whether it amounted to the kind of hardship the law requires. 

That finding lowered her offense level from 33 to 31, which dropped the Guidelines range to 108 to 135 months. Rather than going to the bottom, the court landed in the middle at 123 months. 

There is one more detail worth flagging. The government told the court that Holmes has been advising her current romantic partner on raising money for a startup that features a prototype diagnostic device with what the government described as striking similarities to the Theranos device. She has also told national media outlets that she plans to return to healthcare technology after her release. The court acknowledged these concerns but concluded that her notoriety would subject her to intense scrutiny in any future venture, making it difficult for her to reoffend in the same manner. 

For those of us in the investment world, the uncomfortable takeaway sits right in the middle of the ruling. The investor certifications that opened the door to these private funding rounds – the ones where each investor affirmed they could stomach a complete loss – were used to argue that losing $452 million did not result in the kind of hardship the law requires. The financial resilience of the victims, in effect, worked against them at sentencing. 

Holmes remains in federal prison. The government has not said whether it plans to challenge the reduction.